Skip to main content

Table 4 Robustness for 200 ng mL-1 of BRX (n = 3)

From: Development and validation of a precise flow injection method for the assessment of brexpiprazole, with application to pharmaceutical dosage forms and human plasma analysis

Parameter

 

Recovery͙͙* (%)

Standard deviation

RSD (%)

Flow rate

0.4

101.51

1.67

1.65

0.6

98.79

0.62

0.63

Percentage of acetonitrile (%)

48

99.89

0.40

0.40

52

100.24

1.11

1.11

pH

3.9

101.29

0.80

0.79

4.1

100.27

0.87

0.87

λ excitation (nm)

324

98.52

0.16

0.17

328

99.11

0.79

0.80

λ emission (nm)

362

98.66

0.30

0.31

366

100.22

0.52

0.52

  1. *Mean of three determinations
  2. RSD Relative standard deviation